Comparing Pain and Bruising of Subcutaneous Heparin Injection
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
Subcutaneous heparin injection is one of the most frequent nurses' clinical care. This study aimed to Identify and compare the effects of four different injection duration on pain and bruising associated with subcutaneous injection of heparin in 90 patients. Four injection methods were used for them: A: 10s injections duration B: 10s injection duration and waiting 10s before withdrawing the needle C: 15s injection duration and waiting 5s before withdrawing the needle D: 5s injection duration and waiting 15s before withdrawing the needle. Bruising was measured by a flexible millimeter ruler 48h after each injection; and pain was measured by pain visual analogue scale immediately after the injection. Data will be analyzed by SPSS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2 pain
Started Jan 2011
Typical duration for phase_2 pain
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 19, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedFirst Posted
Study publicly available on registry
July 20, 2012
CompletedJuly 20, 2012
June 1, 2012
1.4 years
May 19, 2012
July 19, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
decrease pain
pain was measured by pain visual analogue scale immediately after the injection.
up to 6 months
bruising
Bruising was measured by a flexible millimeter ruler 48h after each injection
up to 6 months
Study Arms (4)
10s injections duration
EXPERIMENTAL10s injections duration
10s injection duration , waiting 10s
EXPERIMENTAL10s injection duration and waiting 10s before withdrawing the needle
15s injection duration,waiting 5s
EXPERIMENTAL15s injection duration and waiting 5s before withdrawing the needle
5s injection duration , waiting 15s
EXPERIMENTAL5s injection duration and waiting 15s before withdrawing the needle
Interventions
10s injection duration and waiting 10s before withdrawing the needle
15s injection duration and waiting 5s before withdrawing the needle
5s injection duration and waiting 15s before withdrawing the needle
Eligibility Criteria
You may qualify if:
- Inclination to participate in the study; filling out the form of conscious satisfaction
- Ability to answer the questions and determining the rate of pain
- Not being affected by blood clotting difficulties, tissue damages, injuries, and bruises in the site of injection.
You may not qualify if:
- Death,
- Discharge
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- faculty member,MSc of Nursing
Study Record Dates
First Submitted
May 19, 2012
First Posted
July 20, 2012
Study Start
January 1, 2011
Primary Completion
June 1, 2012
Study Completion
June 1, 2012
Last Updated
July 20, 2012
Record last verified: 2012-06